WASHINGTON, DC – The House Energy and Commerce Subcommittees on Energy and Power and Oversight and Investigations today held a joint hearing to discuss a draft of the “No More Solyndras Act.” Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) co-authored the legislation to ensure taxpayers will never again be left on the hook for the administration’s risky bets.
Excerpt: The Energy and Commerce Committee has been closely following the work of the Federal Communications Commission (FCC) and the National Telecommunications and Information Administration (NTIA) regarding the interference dispute between LightSquared Subsidiary LLC ("LightSquared") and the Global Positioning System (GPS) Community.
WASHINGTON, DC – The Subcommittees on Energy and Power and Oversight and Investigations today discussed a draft of the “Smart Energy Act,” bipartisan legislation authored by Reps. Charlie Bass (R-NH) and Jim Matheson (D-UT) aimed at increasing energy efficiency in both the federal government and private sector.
WASHINGTON, DC – The Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing on “RIN Fraud: EPA’s Efforts to Ensure Market Integrity in the Renewable Fuels Program.” Today’s hearing examined the Environmental Protection Agency’s management of fraud in the production and trade of Renewable Identification Numbers, or “RINs,” which serve as credits for the production and blending of renewable fuels and are used for compliance purposes under EPA’s Re
EXAM ROOM: Independent HHS Watchdog Echoes Committee’s Concerns that Obamacare Grants Violate Anti-Lobbying StatutesJuly 11, 2012 | Press Release
The independent Health and Human Services Inspector General is sounding the alarm about potential misuse of taxpayer dollars, highlighting the same concerns Energy and Commerce Committee members have raised that federal dollars funneled through a key Obamacare “slush fund” may have been inappropriately used to finance lobbying campaigns in violation of federal bans on such activity.
FDA reform a triumph for patients and jobs in Michigan The Detroit News By Rep. Fred Upton There aren't a lot of success stories coming out of Washington these days, but here's one you should know about. Congress recently passed the Food and Drug Administration (FDA) Safety and Innovation Act, a measure I authored as the chairman of the House Energy and Commerce Committee.